SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

The community is currently debating the long-term potential of KTA, with many users highlighting its high transaction speed and perceived institutional ties as major catalysts for future growth. While some investors remain cautious about the project's recent price volatility and marketing approach, bulls are actively accumulating and pointing to upcoming infrastructure developments as key drivers for long-term value.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy is actively rallying around this crypto token, drawing heavy community focus through coordinated social media campaigns and comparisons to their past EV stock experiences. Investors are heavily debating the token's long-term legitimacy and potential for a resurgence, while others remain skeptical due to its association with historical market volatility.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing a critical decision zone, with community sentiment divided between bulls anticipating a breakout and bears concerned about potential downside risk from technical levels. Investors are actively debating the long-term viability of the asset and its performance relative to broader market trends, while also discussing the impact of external catalysts and regulatory developments on future price action.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is trending following a strategic partnership with DS Dansuk to advance microreactor deployment in South Korea, alongside ongoing community enthusiasm for its potential role in powering future AI data centers. Investors are actively debating the company's valuation against its peers as they monitor regulatory milestones and the broader market rotation into nuclear energy infrastructure.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to increased visibility regarding its QNX software integration with major robotics and automotive AI platforms, fueling a shift in narrative toward a growth-oriented IoT and physical AI play. The community is actively discussing the stock's recent price momentum and a potential revaluation as the company pivots away from its legacy history.

Alcoa Corp. engages in the bauxite mining, alumina refining, and aluminum smelting and casting. It operates through the Alumina and Aluminum segments. The Alumina segment consists of a refining system, including the mining of bauxite, which is then refined into alumina, a compound of aluminum and oxygen that is the raw material used by smelters to produce aluminum metal. The Aluminum segment is composed of smelting and casthouse system. The company was founded by Charles Martin Hall on July 9, 1886 and is headquartered in Pittsburgh, PA.

Alcoa Corp

Alcoa is attracting significant attention as investors weigh a combination of favorable long-term metal demand driven by AI infrastructure and data center expansion against structural headwinds, including trade tariff pressures and ongoing operational challenges. The community is actively debating the stock's potential for a breakout, with many focusing on its role in critical supply chains while others remain cautious due to management execution concerns and geopolitical impacts on smelter energy costs.

Harmonic, Inc. engages in the development and sale of video delivery software, products, system solutions, and services. It operates through the Video and Broadband segments. The Video segment sells video processing and production and playout services to cable operators, satellite and telecommunications pay-TV service providers, and broadcast and media companies. The Broadband segment offers solutions to cable operators broadband access solutions and related services, including cOS software-based broadband access solution, to broadband operators globally. The company was founded in June 1988 and is headquartered in San Jose, CA.

Harmonic, Inc.

Harmonic, Inc. is trending as traders analyze its structural shift toward a software-centric business model for broadband networks, which has drawn interest for its long-term re-rating potential. The community is actively discussing its exposure to DOCSIS 4.0 upgrades and potential as a long-term infrastructure play amid strong social momentum and institutional interest.

Restaurant Brands International, Inc. is a holding company, which engages in the operation of quick service restaurants. It operates through the following segments: Tim Hortons, Burger King, Popeyes, and Firehouse Subs. The Tim Hortons segment provides donuts, coffee, and tea restaurant services. The Burger King segment manages fast food hamburger restaurants. The Popeyes segment handles the chicken category of the quick service segment of the restaurant industry. The company was founded on August 25, 2014 and is headquartered in Miami, FL.

Restaurant Brands International Inc

Restaurant Brands International is trending as investors react to a positive Q1 earnings report, with the company beating profit expectations across its core brands. Community sentiment remains focused on the long-term potential of the firm's turnaround efforts, including ongoing operational refinements and continued international expansion.

Harvest Portfolios Group Inc - Harvest Tech Leaders Enhanced Income ETF - Class A

Harvest Tech Leaders Enhanced Income ETF - Class A

Investors are closely evaluating HTAE as a diversified option for tech exposure, frequently comparing its enhanced yield and leverage strategy against similar income-focused ETFs. Discussion centers on the benefits of using basket-style ETFs to manage volatility while capturing recurring monthly distributions through covered call strategies.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is attracting significant community attention as investors debate its potential for a supply-driven rally, fueled by its limited 10 million token cap and anticipation surrounding the Clarity Act. While some holders remain bullish on the protocol's long-term utility and institutional promise, others are vocal about their frustration regarding recent price volatility and stiff competition from alternative DeFi protocols.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types

Exelixis, Inc. (Nasdaq: EXEL) today announced presentations for its flagship product, CABOMETYX (cabozantinib), and its investigational oral kinase inhibitor, zanzalintinib, at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting to be held from May 29 June 2 in Chicago. The...

EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study 

Exelixis teams up with Merck to advance zanzalintinib in a phase III colorectal cancer study, expanding its pipeline beyond Cabometyx.

Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer

Exelixis, Inc. (Nasdaq: EXEL) today announced that the company has entered into a clinical development collaboration with Merck, known as MSD outside of the United States and Canada, to supply...

Exelixis (EXEL) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May

Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in May: BofA Securities Health Care Conference 2026...

Exelixis (NASDAQ:EXEL) Price Target Raised to $50.00

Morgan Stanley increased their price objective on Exelixis from $49.00 to $50.00 and gave the company an "equal weight" rating in a report on Wednesday...

Exelixis (NASDAQ:EXEL) Price Target Raised to $47.00

Stifel Nicolaus upped their price objective on Exelixis from $44.00 to $47.00 and gave the stock a "hold" rating in a research report on Wednesday...

EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in Focus 

EXEL beats Q1 EPS estimates on lower costs and buybacks but misses on revenues; Cabometyx sales lag estimates as pipeline progress and new buybacks stay in focus.

Wells Fargo & Company Forecasts Strong Price Appreciation for Exelixis (NASDAQ:EXEL) Stock

Wells Fargo & Company raised their price target on shares of Exelixis from $35.00 to $40.00 and gave the company an "equal weight" rating in a research report on Wednesday...

Here's Why Exelixis (EXEL) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Exelixis, Inc.. The Group's principal activity is to develop innovative therapies for cancer and other serious diseases. Its pharmaceutical programs focuses on discovery and development of small molecule drugs for cancer. The Gruoup has built a multidisciplinary, integrated research and development platform that supports the complex, iterative nature of drug discovery, translational research and clinical development. Its first-generation anticancer product candidates in our clinical pipeline are Spectrum Selective Kinase Inhibitors, that have been optimized for balanced potency, specificity, tolerability and pharmacologic parameters. It operates in the United States.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.84	--	--	N/A
Q1 '26	$0.76	$0.87	13.76%	BEAT
Q4 '25	$0.83	$0.94	13.31%	BEAT
Q3 '25	$0.69	$0.78	13.87%	BEAT
Q2 '25	$0.66	$0.75	14.41%	BEAT

EXEL
Exelixis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest EXEL News

EXELExelixis Inc